Author: Piers Townley

A research team at the University of Texas, led by Professor George Biros have been able to accurately characterise gliomas using a super computer

Professor Frank Winkler and his team at Heidelberg University in Germany have discovered a potential mechanism that could explain glioma recurrence

Our Policy & Public Affairs Manager Cameron Miller, reports from the Conservative Party Conference.

Researchers at The Institute of Cancer Research identify new subgroups for high-grade glial tumours occurring in children

Our Policy & Public Affairs Manager, Cameron Miller, writes from the frontline of the party conference in Brighton

Researchers at Stanford University discover that the absence of a particular protein halts the growth of high-grade gliomas

A diffuse intrinsic pontine glioma (DIPG) diagnosis can be one of the most difficult things for a parent to hear, leaving families feeling helpless and desperately frustrated with the devastating prognosis.

Sarah Lindsell, The Charity’s Chief Executive, has co-signed a letter urging the Secretary of State for Health, Jeremy Hunt, to protect England’s largest annual survey of cancer patient experience in the NHS

We have awarded the Dutch/British WINDOW Consortium a grant of £1.5 million (€1.75 million) for research into Glioblastoma

A team of researchers investigated the effect of the Zika virus on glioblastoma cells in mice, as well as in human brain tissue samples. They discovered that the virus infected and killed the cancerous cells

Sarah Lindsell, our CEO, talks about why gifts in Wills should be in our everyday conversations…

As part of our commitment to improving life today for those affected by brain tumours, we’re excited to announce the expansion of our support offering as we roll out Live Chat

We believe brain tumour patients need a ‘global Britain’ after Brexit. The UK Government has published an important paper outlining its current position on scientific cooperation for when the UK leaves the European Union

Yesterday the UK Government published the recommendations of an independent review of the UK Life Sciences industry

Six years ago, Martino Sclavi was given 18 months to live after a grade 4 glioblastoma brain tumour diagnosis. A side effect of his brain surgery left the film producer unable to read. Words had escaped him

This means that 1/2a clinical trials using the drug VBI-1901 can now begin later this year in patients with recurrent GBM. The trials will examine the safety and effectiveness of the drug

The brain tumour databank launches today. This ground breaking project will revolutionise the way brain tumour data is used worldwide

Thanks to your continued support and fundraising, we’re delighted to announce that we’ve been able to award over £3.8 million to five new exciting research initiatives across the globe

We are delighted to be officially supporting Trustedoctor who have launched the world’s first virtual platform to link patients with leading brain tumour specialists around the world

Our new Young Adult Service aims to help young people aged 16-30 feel less isolated after devastating diagnosis

Earlier today, the English Cancer Patient Experience Survey was published, providing an insight into the experience of 72,288 cancer patients over the age of 16 in 2016

Tom heads up The Charity’s drive to raise awareness and funds for vital research

The group of researchers at UCL, funded by The Charity are led by Professor Paolo Salomoni and have discovered that cells are capable of migrating through tissues in the body

Inspired by his sister, Ed’s planning an epic, 1,000 mile UK running challenge